MME and colorectal cancer: CD10 has also been proved to promote cancer formation and chemoresistance in breast cancer (8), colorectal cancer (29) and malignant melanoma (20), involving mechanisms such as providing a survival niche for cancer stem cells (8) and promoting epithelial–mesenchymal transition (29).